Thymus Vulgaris Mediated Selenium Nanoparticles, Characterization and its Antimicrobial Activity - An In Vitro Study
Indumathy Pandiyan1, Sri Sakthi. D2*, Meignana Arumugham Indiran3, Pradeep Kumar Rathinavelu4, Rajeshkumar S5
1 Post Graduate, Second Year MDS, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, No.162, Poonamallee
high Road, Chennai 600077, Tamil Nadu, India.
2 Reader, Department of Public Health Dentistry, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University,
No.162, Poonamallee high Road, Chennai 600077, Tamil Nadu, India.
3 Professor and Head of the Department, Department of Public Health Dentistry, Saveetha Dental College, Saveetha Institute of Medical and Technical
Sciences, Saveetha University, No.162, Poonamallee high Road, Chennai 600077, Tamil Nadu, India.
4 Professor, Department of Public Health Dentistry, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University,
No.162, Poonamallee high Road, Chennai 600077, Tamil Nadu, India.
5 Associate Professor, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University,
No.162, Poonamallee high Road, Chennai 600077, Tamil Nadu, India.
*Corresponding Author
Sri Sakthi. D,
Reader, Department of Public Health Dentistry, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, No.162, Poonamallee high
Road, Chennai 600077, Tamil Nadu, India.
Tel: 8122399966
E-mail: drsrisakthiphd@gmail.com
Received: April 28, 2021; Accepted: July 09, 2021; Published: July 28, 2021
Citation:Indumathy Pandiyan, Sri Sakthi. D, Meignana Arumugham Indiran, Pradeep Kumar Rathinavelu, Rajeshkumar S. Thymus Vulgaris Mediated Selenium Nanoparticles,
Characterization and its Antimicrobial Activity - An In Vitro Study. Int J Dentistry Oral Sci. 2021;8(7):3516-3521.doi: dx.doi.org/10.19070/2377-8075-21000718
Copyright: Sri Sakthi. D©2021. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
Background: Among all other nanoparticles, selenium nanoparticles (SeNP) is one of the most extensively studied nanoparticle
which has zero oxidation state, nontoxic and biologically inert nature. This is the reason why Selenium is considered as a
major nanoparticle. In this study SeNPs were synthesized using leaf extract of Thymus vulgaris.
Aim: The aim of the present study was to characterize and to assess the antimicrobial efficacy of selenium nanoparticles
reinforced with the herb Thymus vulgaris against oral pathogens.
Methods: The organisms used were Streptococcus mutans, Staphylococcus aureus, Lactobacillus sp and Candida albicans.
Agar well diffusion method was used to assess the antimicrobial efficacy of the nanoparticles at various concentration that
ranges from 25 µL, 50 µL and 100 µL. The synthesized nanoparticles were characterized by using ultraviolet double beam
spectrophotometer in the wave length range of 250-750nm.
Results: Zone of inhibition was found to be highest at 100 µL concentration against Staphylococcus aureus and Candida
albicans. The mean zone of inhibition was found to be increased as the concentrations of Se NPs increased.
Conclusion: Findings from this study suggest that selenium nanoparticles reinforced with Thymus vulgaris extracts act as a
potential antimicrobial agent and can be used as an alternative to commercially available antimicrobial drugs.
2.Introduction
6.Conclusion
8.References
Keywords
Anti-Microbial; Oral Pathogens; Selenium Nanoparticles; Thymus Vulgaris.
Introduction
There has been increasing concern in the era of antibiotic resistance
as bacteria rapidly continue to develop adaptive counter
measures against conventional antibiotics [1]. Bacteria are potentially
life-threatening agents, capable of promoting infectious
diseases. The history of bacteria acting as causative agents for
infection goes back to the 14th century. Salvarsan was the first
antimicrobial agent introduced in 1910. Soon after that, other
antimicrobial agents such as chloramphenicol, nalidixic acid, and
macrolides were used worldwide. The 20th century experienced
temporary relief to infectious bacterial pathogens. Nevertheless,
overexposure to antibiotics and evolution of effective countermeasures
against antibacterial agents led to the emergence of
antibiotic-resistant bacteria [2]. The economic impact of antimicrobial-
drug resistance is escalating at an alarming rate due to the
mounting medical and human cost [3].
Antibiotic resistance currently spans all known classes of natural
and synthetic compounds leading to an urgent requirement for
new drugs and alternatives. But very few novel antibiotics have
been discovered in the past 40 years due to the cost and complexities
associated with drug discovery and development [4]. The
search for new antimicrobial agents or modifications in already
existing ones to improve their antimicrobial activity becomes indispensable.
Nanotechnology provides a good platform to alter
physico-chemical properties of different materials compared to
their bulk counterpart that can be harnessed for bio applications
[5-7].
Generally, metallic NPs are synthesized from inorganic metals by
several chemical methods including gas condensation, attrition,
precipitation, implantation, pyrolysis and hydrothermal treatment
[8]. These methods employ many chemical reagents or consume
excessive energy to progress the NP synthesis reactions by a multistep
process. Chemical precursors and toxic solvents in the reaction
pots are ultimately considered as hazardous wastes, threatening
the living environment and human health [9].
Currently, an alternative method has developed based on the usage
of biological reagents, which have more advantages over the
chemical synthesis. These methods are known as green synthesis
in which a living system such as bacteria, fungi, algae and plant
extracts are often responsible for the reduction of metals for NPs
formation [10].
Besides, synthesis of various types of metal NPs using plant
extracts is found to be more efficient, easily controllable due to
the existence of various metabolites like emulsifying, capping
and stabilizing agents [11]. Reports of the reduction of precious
metals by inactivated plant materials date back almost 100 years.
Molisch [12] and Iwase [13] studied the reduction of Ag by plant
chlorophyll and the reduction of Au by extract of fresh leaves,
respectively. About 66 years ago, Nagai [14] reported the reduction
of Ag(NO)3 by plant cells. A decade ago, Armendariz et al.
[15] reported the bio reduction of KAuCl4 by powdered wheat
(Triticumaestivum) and oat (Avena sativa) biomasses and the subsequent
formation of Au NPs. These researchers reported that
the solution pH is a key variable to control the size and to reduce
the polydispersity of the biogenic Au NPs.
In recent years, several studies have pointed out the ability of selenium
nanoparticles to exhibit anticancer, antioxidant, antibacterial
and anti-biofilm properties. Selenium, being an indispensable dietary
trace element, has been recently introduced in biomedicine
as a 'Drug nanocarrier’. A lot of research has reported that Selenium
possesses strong antioxidant, antibacterial and anticancer
properties [16].
Selenium plays a crucial part in boosting immunity, protecting tissues
against oxidative stress, Reproduction, growth, development
and modulation [17]. Between Selenium’s bioactivity and toxicity,
there exists a thin margin only. Selenium shows immense biological
activity, bioavailability and less toxicity if synthesized biologically
rather the physicochemical methods [18]. So far, remarkable
antimicrobial activity of these nanoparticles have been evidenced
against pathogenic bacteria, fungi and yeasts [19].
So, with this note, in traditional medicine, Thymus genus is employed
for treating spasms, inflammation, and bloat in the ruminant
digestive system [20]. Thyme is an Iranian flora, naturally
distributed in the mountainous semi-grazing areas and grows as
the perennial subshrubs [21]. In the current years, the therapeutic
potential of thyme extract was approved by many studies such
as the treatment of retinal neovascularization, immunodeficiency
syndrome, infection and cancer [22-24].
The rationale of this study is that no study has been conducted so
far in which the antimicrobial properties of Selenium nanoparticles
reinforced with Thymus vulgaris have been assessed. Hence
the aim of the study was to assess the antimicrobial efficacy of
Selenium nanoparticles reinforced with Thymus vulgaris against
oral pathogens.
Materials and Methods
Collection and preparation of plant extract (fig 1)
Powdered Thymus leaves were purchased from the market of
South India and identified and authenticated by Botanist. The obtained
powder of Thymus vulgaris is stored in an airtight container.
One gram of Thymus vulgaris powder was dissolved in 40 ml of
distilled water and boiled for 20 minutes using heating mantle at
60-70oC. The extract was filtered using Whatman No 1 filter paper
and allowed to stand undisturbed for 20 minutes. Then the
filtered plant extract was transferred to an airtight container and
used for green synthesis and further studies.
Preparation of Selenium nanoparticles (fig 2 and 3)
30mMof sodium selenite was weighed and mixed with distilled
water of 60 ml. The sodium selenite solution was mixed with
40ml of filtered plant extract and kept in a magnetic stirrer for 1
hour and kept in a shaker for 72 hours to obtain green synthesized
selenium nanoparticles. UV spectrophotometer periodically monitored
the reduction of sodium selenite to selenium nanoparticles.
The color change was visually noted and photographed. Using
Lark refrigerated centrifuge, the selenium nanoparticles solution
is centrifuged at 8000 rpm for 10 min, and the pellet is collected
and washed with distilled water twice. The final purified pellet was
collected and dried at 100-1500C for 24 h, and finally, the nanoparticles
was stored in an airtight Eppendorf tube.
Characterization of Selenium Nanoparticles
The synthesized selenium nanoparticles solution is primarily characterized
by using Ultraviolet(UV) Visible spectroscopy. 3ml of
the solution was taken in the cuvette and scanned in double-beam
UV- visible spectrophotometer from 250-750 nm wavelength.The
results were recorded for the graphical analysis. The shape and
size of the copper nanoparticles were analyzed by using Transmission
Electron Microscope (JEOL JEM3100F). The crystalline
nature of the nanoparticles was characterized by X-ray diffraction
analysis and the Fourier transform infrared spectroscopy was
used to detect the functional and chemical group in the range of
4000–400 cm.
Antimicrobial Activity
Media Preparation: Mueller Hinton agar for Streptococcus mutans, Staphylococcus aureus, Lactobacillussp and SDA agar for-
Candida albicans and was prepared, sterilized and poured onto
the Petriplates. The plates were allowed for solidification. Agar
Well Diffusion method was used to assess the antimicrobial efficacy.
Swabbing: After solidification, the respective plates were
swabbed with the oral pathogens-Streptococcus mutans, Staphylococcus
aureus, Lactobacillusspand Candida albicans.
Well Formation: After swabbing, three wells on each plate were
formed using a gel puncher. To those three wells, selenium nanoparticles
with Thymus vulgaris solution were loaded in the
concentration range of 25 µL, 50 µL and 100 µL. The plates
were then incubated at 37oC for 24 h for Streptococcus mutans,
Staphylococcus aureus, Lactobacillus spand 48 h for Candida albicans.
After incubation, the zone of inhibition was measured and
calculated.
Results
UV Visible Spectroscopy
UV-Vis absorption spectra of the green synthesized selenium
nanoparticles were recorded at a different wavelength from 250-
750nm. The selenium nanoparticles are synthesized using sodium
selenite and Thymus vulgaris leaf extract as a reducing agent
which shows absorption peak at 340 nm. Broadened SPR peak
observed in this UV-Vis spectrum confirmed that polydispersenano
sized particles. The peak found in the spectroscopy indicates
the formation of Thymus vulgaris selenium nanoparticle.
Transmission electron microscopy (Figure 4)
Figure 3. 3A- Plant extract with sodium selenite, day 1 color change; 3B- Day 2 color change; 3C- Day 3 color change.
Figure 5. Antibacterial activity of selenium nanoparticles reinforced with thymus vulgaris extract against Streptococcus mutans(5A)and Streptococcus aureus(5B). Against S.mutans the zone of inhibition at 25µl, 50µl, 100µl was 9mm at all concentration. Against S.aureus the zone of inhibition at 25µl, 50µl, 100µl was 10mm, 12mm, 18mm respectively.
Figure 6. Antibacterial activity of selenium nanoparticles reinforced with thymus vulgaris extract against Candida albicans (6A)and Lactobacillus (6B). Against C. albicans the zone of inhibition at 25µl, 50µl, 100µl was 9mm, 9mm, 10mm respectively. Against Lactobacillus the zone of inhibition at 25µl, 50µl, 100µl was 9mm, 10mm, 20mm respectively.
TEM is the most common tool to convict the structure, size, morphology, dispersion, and orientation of biological and physical samples. Figure 4 shows the typical TEM images of nanoselenium shape which was found to be spherical and has the broad size distribution between 5–70 nm.
Antimicrobial activity
The diameter of the inhibition zone for all tested concentrations of SeNPs achieved for bacterial strains is presented in Table 1. Figure 5 depicts the antimicrobial activity of seleniumnanoparticles reinforced with thymus vulgaris extract against Streptococcus mutans and Staphylococcus aureus. Zone of inhibition against Streptococcus mutans was found to be almost equal for all concentrations (9 mm). Zone of inhibition against Staphylococcus aureusat 25 µL was 10 mm, at 50 µL was 12 mm and at 100 µL was 18 mm. Figure 6 depicts the antimicrobial activity of selenium nanoparticles reinforced with thymus vulgaris extract against Lactobacillus spand Candida albicans. Zone of inhibition against Lactobacillus sp at 25 µL was 9 mm, 50 µL was 9 mm and at 100 µL was 10 mm. Zone of inhibition against Candida albicans at 25 µL was 9 mm, 50 µL was 10 mm and at 100 µL was 20 mm. So, it was seen that as the concentration of the selenium nanoparticles reinforced with Thymus vulgaris extract increased, the antimicrobial activity increased.
Discussion
Now microorganisms have become resistant to many antibiotics
due to increased use of drugs, which is decreasing efficiency of
conventional medicines. So, it has become necessary to find out
new antimicrobial agents. Nanotechnology is an emerging technology
and has led to a new revolution in every field of science.
Among the various inorganic nanoparticles available, selenium
has easy processing methods, is inexpensive, has a wide range of
applications in dentistry and is a safe material [25].
The studies by author Chudobovaet al, Webster et al, Wang et
alfound that Se NPs may inhibit the growth of S. aureus by up to
60 times compared with the control [26-28]. Webster et alused Se
NPs (80-220 nm) in an antibacterial coating to inhibit the growth
of this pathogen. Inhibitory effects were observed at early time
points (up to 5 h) using Se NPs-coated biofilms as compared to
the uncoated counterpart [27]. Although our results aren’t agreement
with these findings, showing the antimicrobial effect of Se
NPs to S. aureus, we show that Se NPs are a potent antibacterial
agent to S. aureus.
The different types of analysis such as HR-TEM and UV visible
spectroscopy are carried out to study the characteristics of
the selenium nanoparticles. The nanoparticles synthesized are of
100–250 nm with identical sphere structure. The selenium NPs
synthesized from actinobacteria has activity against dengue virus
[30]. Enterococcus faecalis are able to synthesize selenium NPs
from sodium selenite. The characteristics of the NPs are analyzed
using TEM and UV-spectroscopy. TEM reveals that the size of
the NPs is 29-195 nm and is spherical in shape [30]. The bacterial
protein of Zooglearamigera is responsible for the reduction of
selenium nanoparticles. The prepared nanoparticles are hexagonal
phase nanocrystals. XRD, TEM, SEM, SAED, and DLS are
carried out to test the characteristics of the nanoparticles which
reveals that the SeNPs is 30-150 nm and spherical in shape [31].
In a study done by El-Ghazalyet al., regarding the anti-inflammatory
effect of selenium nanoparticles on the inflammation induced
on irradiated rats, Nano-Se were administered orally in a
dose of 2.55 mg/kg. It has been found that Nano-Se lessened the
elevating inflammation in both irradiated and non-irradiated rats
[32]. Melatonin-SeNPs treatment decreased pathological abnormalities
of the liver, proinflammatory cytokines and splenocyte
proliferation. The combination of silymarin and selenium nanoparticle
at Low concentration is an excellent candidate possessing
anti-inflammatory as well as antioxidant properties [33]. Nanoparticles
are endorsed as sustainable antimicrobial agents having
remarkable perspective to resolve the microbial multidrug resistance
problem [34-35]. From the present results, it is indicated that
the biosynthesized SeNPs mediated by thymus extract has the efficient
antimicrobial activity against pathogenic organisms.
Conclusion
In this study, Thymus vulgaris mediated selenium nanoparticles have
been synthesized. This bioengineered nanoparticle has proved to
exhibit significant anti-microbial properties with higher concentrations.
It is non-toxic, without any side effects as that of steroidal
and non-steroidal anti-inflammatory drugs. Future studies
will be carried out to identify other properties present in selenium
nanoparticles synthesized using Thymus vulgaris.
References
- Rösler M, Bayer T, Anand R, Cicin-Sain A, Gauthier S, Agid Y, et al. Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trialCommentary: Another piece of the Alzheimer's jigsaw. Bmj. 1999 Mar 6;318(7184):633-40.
- Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, et al. Inflammation and Alzheimer’s disease. Neurobiol. Aging. 2000 May 1;21(3):383- 421.
- Tuppo EE, Arias HR. The role of inflammation in Alzheimer's disease. Int. J. Biochem. Cell Biol. 2005 Feb 1;37(2):289-305.
- Bourgeois D, Inquimbert C, Ottolenghi L, Carrouel F. Periodontal Pathogens as Risk Factors of Cardiovascular Diseases, Diabetes, Rheumatoid Arthritis, Cancer, and Chronic Obstructive Pulmonary Disease-Is There Cause for Consideration? Microorganisms. 2019 Oct 9;7(10):424.Pubmed PMID: 31600905.
- Zardawi F, Gul S, Abdulkareem A, Sha A, Yates J. Association between periodontal disease and atherosclerotic cardiovascular diseases: revisited. Front. Cardiovasc. Med. 2020;7.
- Pizzo G, Guiglia R, Russo LL, Campisi G. Dentistry and internal medicine: from the focal infection theory to the periodontal medicine concept. Eur. J. Intern. Med. 2010 Dec 1;21(6):496-502.
- Madianos PN, Bobetsis YA, Offenbacher S. Adverse pregnancy outcomes (APO s) and periodontal disease: pathogenic mechanisms. J. Clin. Periodontol. 2013 Apr;40:S170-80.
- López NJ, Smith PC, Gutierrez J. Periodontal therapy may reduce the risk of preterm low birth weight in women with peridotal disease: a randomized controlled trial. J. Periodontol. 2002 Aug;73(8):911-24.
- Kumar PS. From focal sepsis to periodontal medicine: a century of exploring the role of the oral microbiome in systemic disease. J Physiol. 2017 Jan 15;595(2):465-476.Pubmed PMID: 27426277.
- Cullinan MP, Seymour GJ. Periodontal disease and systemic illness: will the evidence ever be enough? Periodontol 2000. 2013 Jun;62(1):271-86.Pubmed PMID: 23574472.
- Fox M, Knorr DA, Haptonstall KM. Alzheimer's disease and symbiotic microbiota: an evolutionary medicine perspective. Ann N Y Acad Sci. 2019 Aug;1449(1):3-24.Pubmed PMID: 31180143.
- Benassi B, Consales C. Environmental Impact on the Etiology of Alzheimer’s Disease: Mechanistic Insights from Oxidative Stress and Epigenetic Perspective. Frontiers in Clinical Drug Research-Alzheimer Disorders. 2014 Nov 24;2:2155.
- Torrungruang K, Jitpakdeebordin S, Charatkulangkun O, Gleebbua Y. Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, and Treponema denticola/Prevotella intermedia Co-Infection Are Associated with Severe Periodontitis in a Thai Population. PLoS One. 2015 Aug 27;10(8):e0136646.Pubmed PMID: 26313005.
- Dominy SS, Lynch C, Ermini F, Benedyk M, Marczyk A, Konradi A, et al. Porphyromonas gingivalis in Alzheimer's disease brains: Evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv. 2019 Jan 23;5(1):eaau3333.Pubmed PMID: 30746447.
- Ivanova L, Karelson M, Dobchev DA. Multitarget Approach to Drug Candidates against Alzheimer's Disease Related to AChE, SERT, BACE1 and GSK3ß Protein Targets. Molecules. 2020 Apr 17;25(8):1846.Pubmed PMID: 32316402.
- Villemagne VL, Furumoto S, Fodero-Tavoletti MT, Mulligan RS, Hodges J, Harada R, et al. In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease. Eur. J. Nucl. Med. Mol. Imaging. 2014 May;41(5):816-26.
- Singhrao SK, Harding A, Poole S, Kesavalu L, Crean S. Porphyromonas gingivalis Periodontal Infection and Its Putative Links with Alzheimer's Disease. Mediators Inflamm. 2015;2015:137357.Pubmed PMID: 26063967.
- Olsen I, Singhrao SK. Is there a link between genetic defects in the complement cascade and Porphyromonas gingivalis in Alzheimer’s disease?. J Oral Microbiol. 2020 Jan 1;12(1):1676486.
- Yuan X, Liu Y, Li G, Lan Z, Ma M, Li H, et al. Blockade of Immune-Checkpoint B7-H4 and Lysine Demethylase 5B in Esophageal Squamous Cell Carcinoma Confers Protective Immunity against P. gingivalis Infection. Cancer Immunol Res. 2019 Sep;7(9):1440-1456.Pubmed PMID: 31350278.
- Wang J, Dai J, Liu B, Gu S, Cheng L, Liang J. Porphyromonas gingivalis lipopolysaccharide activates canonical Wnt/ß-catenin and p38 MAPK signalling in stem cells from the apical papilla. Inflammation. 2013 Dec;36(6):1393-402.Pubmed PMID: 23818055.